Emmanuel Griessinger

Nice, France

Last Updated: 09/26/2026

Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 26 publications

A bispecific antibody-drug conjugate targeting CD7 and CD33 shows anti-tumor activity and improved tumor selectivity in an aggressive subtype of acute myeloid leukemia.

A bispecific antibody-drug conjugate targeting CD7 and CD33 shows anti-tumor activity and improved tumor selectivity in an aggressive subtype of acute myeloid leukemia.

Journal: mAbs
Published: September 01, 2025

A metabolism-specific drug-repurposing screen reveals itraconazole as a potent OXPHOS inhibitor in acute myeloid leukemia.

A metabolism-specific drug-repurposing screen reveals itraconazole as a potent OXPHOS inhibitor in acute myeloid leukemia.

Journal: Blood
Published: December 03, 2024

A metabolism-specific drug-repurposing screen reveals itraconazole as a potent OXPHOS inhibitor in acute myeloid leukemia.

A metabolism-specific drug-repurposing screen reveals itraconazole as a potent OXPHOS inhibitor in acute myeloid leukemia.

Journal: Blood
Published: December 03, 2024

High mtDNA content identifies oxidative phosphorylation-driven acute myeloid leukemias and represents a therapeutic vulnerability.

High mtDNA content identifies oxidative phosphorylation-driven acute myeloid leukemias and represents a therapeutic vulnerability.

Journal: Signal transduction and targeted therapy
Published: September 07, 2024

Mitohormesis: a key driver of the therapy resistance in cancer cells

Mitohormesis: a key driver of the therapy resistance in cancer cells

Journal: Comptes rendus biologies
Published: March 21, 2024

Automated cell type annotation and exploration of single-cell signaling dynamics using mass cytometry.

Automated cell type annotation and exploration of single-cell signaling dynamics using mass cytometry.

Journal: iScience
Published: October 16, 2023

Oxidative Phosphorylation Fueled by Fatty Acid Oxidation Sensitizes Leukemic Stem Cells to Cold.

Oxidative Phosphorylation Fueled by Fatty Acid Oxidation Sensitizes Leukemic Stem Cells to Cold.

Journal: Cancer research
Published: April 17, 2023

The PIP4K2 inhibitor THZ-P1-2 exhibits antileukemia activity by disruption of mitochondrial homeostasis and autophagy.

The PIP4K2 inhibitor THZ-P1-2 exhibits antileukemia activity by disruption of mitochondrial homeostasis and autophagy.

Journal: Blood cancer journal
Published: August 31, 2022

NSG-S mice for acute myeloid leukemia, yes. For myelodysplastic syndrome, no.

NSG-S mice for acute myeloid leukemia, yes. For myelodysplastic syndrome, no.

Journal: Haematologica
Published: June 06, 2018

Intercellular mitochondria trafficking highlighting the dual role of mesenchymal stem cells as both sensors and rescuers of tissue injury.

Intercellular mitochondria trafficking highlighting the dual role of mesenchymal stem cells as both sensors and rescuers of tissue injury.

Journal: Cell cycle (Georgetown, Tex.)
Published: March 28, 2018

Dexamethasone in hyperleukocytic acute myeloid leukemia.

Dexamethasone in hyperleukocytic acute myeloid leukemia.

Journal: Haematologica
Published: November 08, 2017

Acute myeloid leukemia xenograft success prediction: Saving time.

Acute myeloid leukemia xenograft success prediction: Saving time.

Journal: Experimental hematology
Published: October 13, 2017
Showing 1-12 of 26

Last Updated: 09/26/2026